Pharmacogenomics Results Affect Patients' Plan of Care and Changes in Medication Prescription(s)
Medical Provider Experience and Assessment on Documenting Prescribing and Plan of Care Changes Due to Pharmacogenomics Testing
Sponsor: Data Collection Analysis Business Management
A observational or N/A phase clinical study on Pharmacogenomic, this trial is ongoing. The trial is conducted by Data Collection Analysis Business Management and has accumulated 12 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Feb 2021 — Jul 2024 [monthly]
Unknown Status
Status: Enrolling By Invitation → Unknown Status
-
Jan 2021 — Feb 2021 [monthly]
Enrolling By Invitation
-
Feb 2019 — Jan 2021 [monthly]
Enrolling By Invitation
▶ Show 7 earlier versions
-
Nov 2018 — Feb 2019 [monthly]
Enrolling By Invitation
-
Oct 2018 — Nov 2018 [monthly]
Enrolling By Invitation
-
Sep 2018 — Oct 2018 [monthly]
Enrolling By Invitation
-
Jul 2018 — Sep 2018 [monthly]
Enrolling By Invitation
Status: Active Not Recruiting → Enrolling By Invitation
-
Jun 2018 — Jul 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Nov 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
First recorded
Mar 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Data Collection Analysis Business Management
- PAS Research Services
For direct contact, visit the study record on ClinicalTrials.gov .